Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjneurology logo
VJDementia
Logo
  • Home (current)
  • Diseases
    Alzheimer's Disease
    Dementia
    Dementia with Lewy Bodies
    Frontotemporal Dementia
    Vascular Dementia
    Mild Cognitive Impairment
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Communication
    Treatment
    Care Practice
    Prevention
    View all Topics
  • Conferences
    ARUK 2023
    CTAD 2022
    AAIC 2022
    EAN 2022
    ESOC 2022
    AAN 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

COR388

Developing gingipain inhibitors for the treatment of Alzheimer’s disease 2:33
Developing gingipain inhibitors for the treatment of Alzheimer’s disease
Michael Detke • 28 Jul 2021
COR388: a novel approach to treating Alzheimer’s based on the gingipain hypothesis 3:10
COR388: a novel approach to treating Alzheimer’s based on the gingipain hypothesis
Michael Detke • 28 Jul 2021
Targeting P. gingivalis infection to treat Alzheimer’s: the evidence 10:20
Targeting P. gingivalis infection to treat Alzheimer’s: the evidence
Michael Detke • 28 Jul 2021
Phase II/III GAIN trial of a novel lysine-gingipain inhibitor for the treatment of Alzheimer’s 2:46
Phase II/III GAIN trial of a novel lysine-gingipain inhibitor for the treatment of Alzheimer’s
Michael Detke • 28 Jul 2021
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJDementia via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJDementia logo
The content of VJDementia is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy